Kernal Biologics

Kernal Bio (Kernal Biologics) is a Boston-based TechBio company engineering cells inside the body using AI-designed, cell-selective mRNA and targeted lipid nanoparticles, an approach intended to generate CAR-T cells directly in vivo without ex vivo manufacturing. Its lead candidate KR-402, an mRNA-encoded in vivo CAR-T therapy built on its mRNA 2.0 platform, is in development for B-cell malignancies such as follicular lymphoma and for autoimmune diseases including multiple sclerosis. Founded by a team with backgrounds at MIT, Harvard, Merck and BMS, the Y Combinator-backed company is supported by investors including Amgen Ventures, Hummingbird Ventures, IFLI, HBM and Civilization Ventures, alongside up to 48 million USD in non-dilutive ARPA-H funding.

  • AI/ML
  • Biotechnology
  • Healthtech
  • Healthcare & Life Sciences

1

Round

1

Industry

3

Tags

Nov 17, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Nov 17, 2026

    Undisclosed

    Led by IFLI

    • IFLI

    Article coming soon.

Pricing

Research Kernal Biologics — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if Kernal Biologics is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational